Developing a tool to measure contributions to medication-related processes in family practice

Journal of Interprofessional Care

Volumn 22, Issue 1, 2008, Pages 17-29

  Farrell, Barbara ^a   Pottie, Kevin ^a   Woodend, Kirsten ^b   Yao, Vivian Hua ^c   Kennie, Natalie ^d   Sellors, Connie ^e   Martin, Carmel ^f   Dolovich, Lisa ^g  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c BRUYÈRE RESEARCH INSTITUTE   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^g CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

Family physicians; Interprofessional team; Medication; Pharmacists; Questionnaire

Indexed keywords

DRUG;

ARTICLE; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DRUG USE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INTERDISCIPLINARY COMMUNICATION; INTERNAL CONSISTENCY; MALE; MEDICAL DOCUMENTATION; NURSE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PILOT STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY ANALYSIS; TEST RETEST RELIABILITY; VALIDATION STUDY;

FAMILY PRACTICE; FEMALE; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; NURSES; PATIENT CARE TEAM; PHARMACISTS; PHYSICIANS, FAMILY; PILOT PROJECTS; PSYCHOMETRICS;

EID: 38549115183     PISSN: 13561820     EISSN: 14699567     Source Type: Journal    
DOI: 10.1080/13561820701828845     Document Type: Article

References (24)

1. Bajcar, J., Kennie, N. and Einarson, T. (2005) Collaborative medication management in a team-based primary care practice: An explanatory conceptual framework. Research in Social and Administrative Pharmacy, 1, pp. 408-429.
2. Bates, D., Cullen, D., Laird, N., Petersen, L., Small, S. and Servi, D. (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. Journal of the American Medical Association, 274, pp. 29-34.
3. Bloom, J., Frank, J., Shafir, M. and Martiquet, P. (1993) Potentially undesirable prescribing and drug use among the elderly. Measurable and remediable. Canadian Family Physician, 39, pp. 2337-2345.
4. Carmichael, J., O'Connell, M., Devine, B., Kelly, H., Ereshefsky, L. and Linn, W. (1997) Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy. Pharmacotherapy, 17, pp. 1050-1061.
5. Col, N., Fanale, J. and Kronholm, P. (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Archives of Internal Medicine, 150, pp. 841-845.
6. Crocker, L. and Algina, J. (1986) Introduction of classical and modern test theory, Holt, Rinehart and Winston Inc., Fort Worth
7. Dieleman, S., Farris, K., Feeny, D., Johnson, J., Tsuyuki, R. and Brilliant, S. (2004) Primary health care teams: Team members' perceptions of the collaborative process. Journal of Interprofessional Care, 18, pp. 75-78.
8. Dunn, G. (1989) The design and analysis of reliability studies: The statistical evaluation of measurement errors, pp. 45-50. Oxford University Press, New York
9. Einarson, T. (2005) The Authority Pharmacotherapy Care Model: An explanatory model of the drug use process. Research in Social & Administrative Pharmacy, 1, pp. 101-117.
10. Farris, K. (2005) Relationships & responsibilities are critical to team care in medication management. Research in Social & Administrative Pharmacy, 1, pp. 369-374.
11. Feinstein, A. (1987) The theory and evaluation of sensibility. Clinimetrics, pp. 141-166. Yale University, New Haven, CT
12. Fish, A., Watson, M. and Bond, C. (2002) Practice-based pharmaceutical services: A systematic review. International Journal of Pharmacy Practice, 10, pp. 225-233.
13. Guyatt, G., Kirshner, B. and Jaeschke, R. (1992) Measuring health status: What are the necessary measurement properties?. Journal of Clinical Epidemiology, 45, pp. 1341-1354.
14. Guyatt, G., Jaeschke, R., Feeny, D. and Patrick, D. (1996) Measurements in clinical trials: Choosing the right approach. Quality of life and pharmacoeconomics in clinical trials, pp. 41-48. Lippincott-Raven Inc., New York, NY
15. Hallas, J., Harvald, B., Worm, J., Beck-Nielsen, J., Gram, L. and Grodum, E. (1993) Drug related hospital admissions. Results from an intervention program. European Journal of Clinical Pharmacology, 45, pp. 199-203.
16. Koshman, S., Pottie, K. and Viner, G. (2003) Rethinking the way we manage medications. Using pharmacists in community family practice. Canadian Family Physician, 49, pp. 1066-1068.
17. Martin, C. and Rohan, B. (2002) Chronic illness care as a balancing act. A qualitative study. Australian Family Physician, 31, pp. 55-59.
18. Romanow Commission (2002) Building on values: The future of health care in Canada (Final Report. 1 - 356), Commission on the Future of Health Care in Canada, Ottawa
19. Martin-Rodriguez, L. San, Beaulieu, M., D'Amour, D. and Ferrada-Videla, M. (2005) The determinants of successful collaboration: A review of theoretical and empirical studies. Journal of Interprofessional Care, 19, pp. 132-147.
20. Sellors, J., Kaczorowski, J., Sellors, C., Dolovich, L., Woodward, C. and Willan, A. (2003) A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Canadian Medical Association Journal, 169, pp. 17-22.
21. Smith, M. and Knapp, D. (1992) Drug use. Pharmacy, drugs and medical care, Williams and Wilkins, Baltimore, MD
22. Streiner, D. and Norman, G. (2003) Health measurement scales-A practical guide to their development and use, Oxford University Press, Oxford
23. Urquhart, J. (1996) Patient non-compliance with drug regimens: Measurement, clinical correlates, economic impact. European Heart Journal, 17, pp. 8-15.
24. Way, D., Jones, L. and Busing, N. (2000) Implementation strategies: Collaboration in primary care-family doctors and nurse practitioners delivering shared care. Toronto: The Ontario College of Family Physicians, pp. 1-12.